News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Strategic Technologies for Europe Platform survey
Published on | 2 months ago
Programmes Digital, Industry & Space Agro-Food, Environment Digital EuropeThe Strategic Technologies for Europe Platform (STEP) was set up by the EU to support the European industry and boost investment in critical technologies in Europe. STEP raises and steers funding across 11 EU programmes to three target investment areas:
- Digital technologies and deep-tech innovation
- Clean and resource-efficient technologies
- Biotechnologies
STEP also supports projects growing the skills necessary to develop those critical technologies. STEP introduces a new STEP Seal – an EU label for high quality projects granting STEP projects visibility and facilitating their access to other possible sources of funding.
STEP is currently conducting a brief survey on access to EU funding. In case you are interested in contributing your point of view, you can access the survey here. The survey is open until 27 September 2024.
Related News
|
2024-11-15
|
1 week ago |
Commission consultation on AI Act prohibitions and AI system definition |
|
2024-11-15
|
1 week ago |
First draft of General-Purpose Artificial Intelligence Code of Practice |
|
2024-11-08
|
2 weeks ago |
Update on the 2025 call topics |
|
2024-11-05
|
2 weeks ago |
NCP Flanders team: Reshuffle of responsibilities of our NCP Advisors - Horizon Europe... |
|
2024-11-04
|
2 weeks ago |
Autumn update - Open Cascading Funding calls in the Digital domain |
|
2024-11-04
|
2 weeks ago |
CEF-Digital calls are now open |
|
2024-10-22
|
4 weeks ago |
Commission seeks feedback: implementing act to establish a scientific panel under the... |
|
2024-10-16
|
1 month ago |
Procurement: Development, Consultancy and Support for an Age Verification Solution |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1484 articles available search in articlesDeployment: Best use of technologies
Procurement: Better Internet for Kids (BIK) Platform – EU Coordination
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
Digital, Industry & Space AI, data & cloud
Commission consultation on AI Act prohibitions and AI system definition
The European Commission’s Artificial Intelligence (AI) Office has launched a targeted stakeholders consultation process on the future guidelines on the AI system definition and the implementation of AI practices that pose unacceptable risks under the AI Act. The guidelines will help national competent authorities as well as providers and dep... read more
Digital, Industry & Space AI, data & cloud
First draft of General-Purpose Artificial Intelligence Code of Practice
The European Commission has published the first draft of the General-Purpose Artificial Intelligence (AI) Code of Practice. The rules governing general-purpose AI models under the AI Act will come into application in August 2025. The Code of Practice aims to facilitate the proper implementation of these rules and will play a crucial role in guidin... read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
